SGLT2 inhibitors were not rarely used in patients with diabetes mellitus who underwent femoropopliteal endovascular therapy using a drug coated balloon for symptomatic peripheral artery disease in Japan. The gene discussed is SLC5A2; the disease is peripheral arterial disease.